about
Novel Marine Compounds: Anticancer or Genotoxic?DNA adductomicsBiomarkers in natural fish populations indicate adverse biological effects of offshore oil productionThe influence of diesel exhaust on polycyclic aromatic hydrocarbon-induced DNA damage, gene expression, and tumor initiation in Sencar mice in vivoFuture research needs associated with the assessment of potential human health risks from exposure to toxic ambient air pollutantsMatrix-assisted laser desorption/ionization mass spectrometry of deoxynucleotides labeled with an IMI dye.Screening for DNA adducts by data-dependent constant neutral loss-triple stage mass spectrometry with a linear quadrupole ion trap mass spectrometerMethodological considerations and factors affecting 8-hydroxy-2-deoxyguanosine analysis.Evaluation of biomarkers in plasma, blood, and urine samples from coke oven workers: significance of exposure to polycyclic aromatic hydrocarbons.Biomarkers in disease and health.Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons.Effects of an oil spill in a harbor assessed using biomarkers of exposure in eelpout.DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke.Human DNA adduct measurements: state of the artPossible relevance of pigeons as an indicator species for monitoring air pollution.DNA adducts as exposure biomarkers and indicators of cancer riskHeterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis.Influence of nucleic acid base aromaticity on substrate reactivity with enzymes acting on single-stranded DNA.Biomonitoring of arylamines and nitroarenes.DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes.Adduct detection by acylation with [35S]methionine: analysis of DNA adducts of 4-aminobiphenyl.Analysis of DNA adducts from chemical carcinogens and lipid peroxidation using liquid chromatography and electrospray mass spectrometry.NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductaseBiomarkers of exposure in community settings.Role of biomarkers in monitoring exposures to chemicals: present position, future prospects.32P-post-labelling analysis of DNA adducts formed in the upper gastrointestinal tissue of mice fed bracken extract or bracken sporesLiquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection.Mass spectrometry of structurally modified DNA.The analysis of DNA adducts: the transition from (32)P-postlabeling to mass spectrometry.Polyaromatic hydrocarbon exposure: an ecological impact ambiguity.Determination of bulky DNA adducts in biomonitoring of carcinogenic chemical exposures: features and comparison of current techniques.Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin.Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.32P-postlabeling methods for DNA adduct detection: overview and critical evaluation.Potential biomarkers of benzene exposure.DNA adduct formation in the human nasal mucosa as a biomarker of exposure to environmental mutagens and carcinogens.Analysis of the EPHX1 113 polymorphism and GSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking.Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study.Carcinogen-DNA adducts in human breast epithelial cells.
P2860
Q24804433-AF0B4444-5D56-4F7D-92BE-118836EDAC80Q28384534-4A9DF824-7B74-4F7D-AD33-73CD639307EDQ28744364-D56D4AB8-BF26-4BFD-9AF7-21BC40DA4F93Q28757348-79A70B29-654E-40FF-A916-76F873E05ACAQ28767812-8C30780D-8039-44F1-AB10-5E90738713FFQ30643011-0F04AC5E-7377-45CA-9769-DE068D873D07Q33393357-E1CA0DD8-BD9E-47C5-B73C-F5803525286EQ33546914-38288251-BBA4-4FD2-9B8B-B5A427EF0E46Q33819429-A726719B-AFDC-4708-8AD2-FE77C2B0C657Q34345140-4E07C202-98A3-4156-B3FC-C69421D73443Q34363058-43E52D89-3FCF-418B-880C-B2915D436764Q34538352-3A9B7F4F-30A9-4F3B-B3B6-80ACC43EFE17Q34637005-CCB7C136-CF10-4F4A-9B5B-A8796386AB0BQ34637114-D5DBE1E0-F623-4265-9B08-E7BFBFC4CF7FQ34638584-7C1A621B-5BBB-4C55-8766-49DB60D98946Q34638964-B3B00614-65AA-4D30-9C30-8AA5CAD81381Q34819148-C430AAC7-FE99-4FF9-9D4B-89C895DF1BFDQ34967455-C1ADCEB0-67D6-4544-A454-29A0DB7A95A1Q35001236-68ADD5CE-5DE0-49B9-8BAA-F89C37C7E02CQ35056543-F0238402-E528-43EB-BCCE-7ED43D6C3D01Q35068032-6C7C6C7A-D27C-4D5A-B32E-7DCC5D96D21CQ35122568-3A1F495F-F167-4B00-8C64-6805FCD08914Q35707285-189A2020-BCB6-4736-889D-CD4C39A0C5F0Q35802396-B1469911-D4A1-443E-A056-06133E9C6C24Q36069634-911C686B-81A5-49FB-A912-8AB70BE0EC46Q36136271-16D2F8CD-8BCA-450C-85BD-40E356DFAC09Q36307099-AC375100-8DF1-442B-BAAA-EF6AC20AF25BQ36979806-DB088D9A-31B0-4C1E-98E4-5F621320029BQ36997123-FC33670C-C903-4F5F-AB63-4A4906D01026Q38093073-54F393FB-E177-4F43-8ABD-A88CD2C97628Q38125237-9A5AAFB5-9954-4C23-A5DF-9D5633622B63Q38502784-F58F45CD-EDAB-4E8F-8DF5-A02C7B671C23Q38809034-DEC44590-2BD4-429E-8055-C76150588C2FQ39772698-CF780141-30CE-41AB-9CDE-FFC1B0AE2FF3Q40700913-C594EC33-8774-437E-9E58-0006A2CB6CE1Q41549901-BB88248D-E5B2-4158-A581-168766E7B267Q42428792-273AAFCD-5846-44F1-8837-D008CCB92F4FQ43686473-8F359340-E042-478B-9496-958DB3B15396Q43714457-E4F7F05E-C3B4-4DE1-85D4-E07FF7519B4CQ43938576-C6A35E59-59FB-4BF3-A2A2-451BD12D4CA9
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Human biomonitoring and the 32P-postlabeling assay.
@ast
Human biomonitoring and the 32P-postlabeling assay.
@en
type
label
Human biomonitoring and the 32P-postlabeling assay.
@ast
Human biomonitoring and the 32P-postlabeling assay.
@en
prefLabel
Human biomonitoring and the 32P-postlabeling assay.
@ast
Human biomonitoring and the 32P-postlabeling assay.
@en
P356
P1433
P1476
Human biomonitoring and the 32P-postlabeling assay.
@en
P2093
P304
P356
10.1093/CARCIN/13.7.1053
P407
P577
1992-07-01T00:00:00Z